BRPI0909028A2 - nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos - Google Patents

nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos

Info

Publication number: BRPI0909028A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical compositions; substituted phenyl; covalently linked; linked bicyclic; phenyl oxazolidinones
Prior art date: 2008-03-26

Application number

BRPI0909028A

Other languages

English (en)

Inventor

Adrian Blaser

Andrew M Thompson

Brian Desmond Palmer

Charles Z Ding

Dianjun D Chen

Genliang Lu

Hamish Scott Sutherland

Iveta Kmentova

Jiancheng Wang

Keith Combrink

Minsoo Song

William Alexander Denny

Zhenkun Ma

Original Assignee

Global Alliance For Tb Drug Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-26

Filing date

2009-03-25

Publication date

2015-09-22

2009-03-25 Application filed by Global Alliance For Tb Drug Dev filed Critical Global Alliance For Tb Drug Dev

2015-09-22 Publication of BRPI0909028A2 publication Critical patent/BRPI0909028A2/pt

Links

NCTCGHLIHJJIBK-UHFFFAOYSA-N 3-phenyl-1,3-oxazolidin-2-one Chemical class O=C1OCCN1C1=CC=CC=C1 NCTCGHLIHJJIBK-UHFFFAOYSA-N 0.000 title 1
-1 bicyclic nitroimidazoles Chemical class 0.000 title 1
239000008194 pharmaceutical composition Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

BRPI0909028A 2008-03-26 2009-03-25 nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos BRPI0909028A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7085508P	2008-03-26	2008-03-26
PCT/US2009/038266 WO2009120789A1 (en)	2008-03-26	2009-03-25	Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones

Publications (1)

Publication Number	Publication Date
BRPI0909028A2 true BRPI0909028A2 (pt)	2015-09-22

Family

ID=40821727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909028A BRPI0909028A2 (pt)	2008-03-26	2009-03-25	nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos

Country Status (11)

Country	Link
US (1)	US7666864B2 (pt)
EP (1)	EP2254892B1 (pt)
JP (1)	JP5613656B2 (pt)
CN (1)	CN101965353B (pt)
AU (1)	AU2009228293B2 (pt)
BR (1)	BRPI0909028A2 (pt)
CA (1)	CA2712613C (pt)
NZ (1)	NZ587096A (pt)
RU (1)	RU2504547C2 (pt)
WO (1)	WO2009120789A1 (pt)
ZA (1)	ZA201006824B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9198913B2 (en)	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
EP2459570B1 (en) *	2009-07-31	2014-12-24	Global Alliance For Tb Drug Development	Nitroimidazooxazine analogues and their uses
WO2011014774A1 (en) *	2009-07-31	2011-02-03	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
CN102234287B (zh) *	2010-04-26	2015-08-05	上海阳帆医药科技有限公司	硝基咪唑类化合物、其制备方法和用途
CN103025716B (zh)	2010-04-27	2014-12-24	武田药品工业株式会社	二环化合物衍生物及其作为acc抑制剂的用途
GB201012209D0 (en) *	2010-05-31	2010-09-08	Ge Healthcare Ltd	In vivo imaging agent
US20120065170A1 (en)	2010-09-10	2012-03-15	Micurx Pharmaceuticals, Inc.	Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
EP2616441B1 (en) *	2010-09-17	2019-08-07	Purdue Pharma L.P.	Pyridine compounds and the uses thereof
EP2697232B1 (en) *	2011-04-15	2016-05-18	Otsuka Pharmaceutical Co., Ltd.	6,7-dihydroimidazo[2,1-b][1,3]oxazine bactericides
WO2013044845A1 (zh)	2011-09-29	2013-04-04	山东轩竹医药科技有限公司	联芳基杂环取代的噁唑烷酮抗菌药
WO2013072903A1 (en)	2011-11-17	2013-05-23	Ithemba Pharmaceuticals (Proprietary) Limited	Nitroimidazoxadiazocine compounds
KR101650716B1 (ko) *	2012-11-22	2016-08-24	한국화학연구원	바이시클릭니트로이미다졸 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 결핵의 예방 또는 치료용 약학적 조성물
ES2707362T3 (es) *	2013-10-04	2019-04-03	Council Scient Ind Res	6-nitro-2,3-dihidroimidazo [2,1-b] oxazoles y un procedimiento de preparación de los mismos
KR101564425B1 (ko)	2013-11-26	2015-10-30	한국화학연구원	신규한 바이사이클릭 니트로이미다졸 카바메이트 화합물, 이를 제조하는 방법 및 이를 유효성분으로 함유하는 결핵 질환의 예방 또는 치료용 약제학적 조성물
CN104725330B (zh) *	2013-12-18	2017-06-13	四川好医生药业集团有限公司	噁唑烷酮类化合物及其制备方法和用途
CN104496979A (zh) *	2014-09-17	2015-04-08	博瑞生物医药技术(苏州)有限公司	一种噁唑烷酮类化合物及其中间体的制备方法
KR101682356B1 (ko)	2014-11-04	2016-12-06	한국화학연구원	이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물
CN105732659B (zh) *	2014-12-12	2019-07-16	上海阳帆医药科技有限公司	硝基咪唑类化合物及其制备方法和在制药中的用途
JP6542900B2 (ja)	2015-01-29	2019-07-10	メッドシャインディスカバリーインコーポレイテッド	抗肺結核症のニトロイミダゾール誘導体
CN106317072B (zh) *	2015-06-17	2020-03-17	盟科医药技术(上海)有限公司	用于分枝杆菌感染治疗的杂环化合物及其应用
EP4074378A1 (en)	2015-07-02	2022-10-19	Janssen Sciences Ireland Unlimited Company	Antibacterial compounds
CN113603683B (zh)	2015-07-17	2024-06-14	结核病药物开发全球联盟公司	用于抗微生物治疗的经取代苯基噁唑烷酮
EA201990043A1 (ru)	2016-06-16	2019-05-31	Янссен Сайенсиз Айрлэнд Анлимитед Компани	Антибактериальные соединения
EP4417262A3 (en)	2017-03-01	2024-11-27	Janssen Sciences Ireland Unlimited Company	Combination therapy
CN107827927B (zh) *	2017-09-05	2019-08-09	陕西思尔生物科技有限公司	一种镍催化合成磷酸泰地唑利的方法
CN108047248A (zh) *	2018-02-12	2018-05-18	丹诺医药(苏州）有限公司	噁唑烷酮-硝基咪唑类偶联分子的应用
CN111606900A (zh) *	2019-02-24	2020-09-01	陕西合成药业股份有限公司	一种抗感染药物及其制备方法和应用
CN112300192B (zh) *	2019-08-02	2023-08-11	南京长澳医药科技有限公司	硝基咪唑类化合物及其制备方法和用途
CN113527331B (zh) *	2020-04-17	2024-05-28	南京长澳医药科技有限公司	硝基咪唑类衍生物及其制备方法和用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4921869A (en)	1987-10-09	1990-05-01	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en)	1987-10-09	1989-01-31	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
ES2059467T3 (es)	1987-10-21	1994-11-16	Du Pont Merck Pharma	Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.
US4948801A (en)	1988-07-29	1990-08-14	E. I. Du Pont De Nemours And Company	Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
SK283420B6 (sk)	1992-05-08	2003-07-01	Pharmacia & Upjohn Company	Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en)	1994-08-16	1997-11-18	Pharmacia & Upjohn Company	Substituted oxazine and thiazine oxazolidinone antimicrobials
BR9509673A (pt) *	1994-11-15	1997-09-30	Upjohn Co	Compostos e uso dos mesmos
US6087358A (en) *	1995-06-26	2000-07-11	Pathogenesis Corporation	Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
US5668127A (en) *	1995-06-26	1997-09-16	Pathogenesis Corporation	Nitroimidazole antibacterial compounds and methods of use thereof
GB9702213D0 (en)	1996-02-24	1997-03-26	Zeneca Ltd	Chemical compounds
MY116093A (en)	1996-02-26	2003-11-28	Upjohn Co	Azolyl piperazinyl phenyl oxazolidinone antimicrobials
TWI347946B (en) *	2002-10-11	2011-09-01	Otsuka Pharma Co Ltd	2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
US6962262B2 (en)	2003-02-10	2005-11-08	Dennis Toma	Connecting corner for knock down racks
TW200500360A (en)	2003-03-01	2005-01-01	Astrazeneca Ab	Hydroxymethyl compounds
ES2308171T3 (es)	2003-04-30	2008-12-01	Morphochem Aktiengesellschaft Fur Kombinatorische Chemie	Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
US7687627B2 (en)	2003-09-08	2010-03-30	Wockhardt Limited	Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
WO2005042542A1 (en)	2003-10-31	2005-05-12	Otsuka Pharmaceutical Co., Ltd.	2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
JP2007514782A (ja)	2003-12-17	2007-06-07	リブ−エックスファーマシューティカルズ，インコーポレイテッド	ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
CA2549675C (en) *	2003-12-18	2012-11-20	Morphochem Aktiengesellschaft Fur Kombinatorische Chemie	Oxazolidinone-quinolone hybrid antibiotics
JP4787529B2 (ja) *	2004-04-09	2011-10-05	大塚製薬株式会社	医薬組成物
WO2006022794A1 (en)	2004-07-28	2006-03-02	Rib-X Pharmaceuticals, Inc.	Biaryl heterocyclic compounds and methods of making and using the same
EP1799677A1 (en)	2004-10-08	2007-06-27	Ranbaxy Laboratories Limited	Oxazolidinone derivatives as antimicrobials
WO2006043121A1 (en)	2004-10-20	2006-04-27	Ranbaxy Laboratories Limited	Oxazolidinone derivatives as antimicrobials
RU2008129726A (ru) *	2005-12-23	2010-01-27	Новартис АГ (CH)	Нитроимидазольные производные

2009
- 2009-03-25 CN CN200980108015.7A patent/CN101965353B/zh active Active
- 2009-03-25 US US12/411,220 patent/US7666864B2/en active Active
- 2009-03-25 BR BRPI0909028A patent/BRPI0909028A2/pt not_active Application Discontinuation
- 2009-03-25 JP JP2011502023A patent/JP5613656B2/ja active Active
- 2009-03-25 WO PCT/US2009/038266 patent/WO2009120789A1/en not_active Ceased
- 2009-03-25 NZ NZ587096A patent/NZ587096A/en unknown
- 2009-03-25 AU AU2009228293A patent/AU2009228293B2/en active Active
- 2009-03-25 CA CA2712613A patent/CA2712613C/en active Active
- 2009-03-25 RU RU2010143541/04A patent/RU2504547C2/ru active
- 2009-03-25 EP EP09724981.7A patent/EP2254892B1/en active Active
2010
- 2010-09-23 ZA ZA2010/06824A patent/ZA201006824B/en unknown

Also Published As

Publication number	Publication date
AU2009228293A1 (en)	2009-10-01
CA2712613C (en)	2017-02-28
CA2712613A1 (en)	2009-10-01
US20090281088A1 (en)	2009-11-12
CN101965353A (zh)	2011-02-02
EP2254892B1 (en)	2014-04-23
JP5613656B2 (ja)	2014-10-29
RU2504547C2 (ru)	2014-01-20
WO2009120789A1 (en)	2009-10-01
CN101965353B (zh)	2014-12-17
RU2010143541A (ru)	2012-05-10
NZ587096A (en)	2011-11-25
WO2009120789A8 (en)	2010-10-28
JP2011515487A (ja)	2011-05-19
US7666864B2 (en)	2010-02-23
ZA201006824B (en)	2011-06-29
AU2009228293B2 (en)	2012-11-08
EP2254892A1 (en)	2010-12-01

Legal Events

Date	Code	Title	Description
2017-06-13	B25A	Requested transfer of rights approved	Owner name: TENNOR THERAPEUTICS LIMITED (CN)
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-02-12	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-03-12	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-07-09	B09B	Patent application refused [chapter 9.2 patent gazette]

Publication	Publication Date	Title
LTPA2018014I1 (lt)	2018-12-10	Farmacinė kompozicija 514
EP2240022A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITIONS
BRPI0919942A2 (pt)	2014-12-23	Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt)	2017-05-23	composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt)	2015-12-29	composto, composição farmacêutica, e, uso de um composto
SMT201600259B (it)	2016-08-31	Composizioni farmaceutiche antibatteriche
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
BR112013016772A2 (pt)	2016-10-11	composto, uso do composto, composição farmacêutica, oligonucleotídeo e conjugado
BR112013008259A2 (pt)	2017-12-12	composto, composição farmacêutica, e, uso de um composto
BR112013015397A2 (pt)	2016-09-20	composto, composição farmacêutica, e, uso de um composto
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0918502A2 (pt)	2015-12-01	aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BR112012031226A2 (pt)	2018-03-06	composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112013011448A2 (pt)	2016-08-09	composto, composição farnmacêutica, e, uso do composto
DK3492069T3 (da)	2022-03-14	Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0917001A2 (pt)	2016-02-16	composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BRPI0921879A2 (pt)	2018-10-16	composto, composição farmacêutica , e, uso de um composto
DK2285357T3 (da)	2014-06-02	Farmaceutisk sammensætning omfattende brivaracetam
BRPI0921654A2 (pt)	2016-02-10	formulação farmacêutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
BRPI0906937A2 (pt)	2016-04-19	composto, composição farmacêutica, e, uso de um composto
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
BRPI0921935A2 (pt)	2016-01-05	composições adesivas de uso médico
BRPI0915473A2 (pt)	2015-11-10	composto, composição farmacêutica, e, uso de um composto
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica